Ph : (301) 662-8477
Fax : (301) 662-4293

501 West Seventh Street, Suite 1A
Frederick, Maryland 21701

Directions

Clinical Trials

Clinical Trials are research studies which provide patients with access to the latest therapies while allowing physicians and researchers to evaluate potentially more effective treatment options. Patients may choose to receive these treatments by participating in a Clinical Trial.

Frederick Memorial Hospital and the physicians of Oncology Care Consultants are proud to provide patients access to a wide range of clinical trials. Patients treated in clinical trials often gain access to improved therapies for their diagnosis. Our patients are able to receive their study treatments conveniently and comfortably within FMH's Regional Cancer Therapy Center.

We participate in a variety of Phase 2, 3 and 4 clinical trials that are sanctioned by the National Cancer Institute and that are sponsored by major research institutes, cancer cooperative groups, as well as the pharmaceutical industry.

For more information about clinical trials availability and eligibility, please speak with your physician or contact our Clinical Research Coordinator, Shelley Francella at (301) 668-7043. Additional information about clinical trials can be found at www.cancer.net.

Search Clinical Trials

FMH/OCC Clinical Trials Locator

The Simplicity Study

CHRONIC MYELOID LEUKEMIA (CML) - The purpose of this study is to collect information on the treatment and management of CML. Information about your health status and treatments will be collected and compared to other patients with CML. You will complete questionnaires during the study, and you will be reimbursed for your time and travel expenses.

ADVANCED BREAST CANCER, CHEMOTHERAPY-BASED TREATMENT

C40502 enrolls patients to one of three chemotherapy regimens: Taxol, Ixabepilone,   or Abraxane. Patients may also receive bevacizumab (Avastin).  Patients may not have received prior chemotherapy for advanced breast cancer.

SQUIRE - IMCL CP11-0806

This study is designed to treat patients with advanced SQUAMOUS lung cancer. Patients who have not had any prior chemotherapy treatments will be assigned to receive  either standard treatment  with gemcitabine and cisplatin or  gemcitabine and cisplatin with the investigational drug IMC-11F8.

Emergency Care

If you are having an emergency, please call 911. If you have an urgent problem, we have a physician on call 24 hours a day, 7 days a week. You can reach the physician by calling the office number, (301) 662-8477. After regular office hours, the physician on call will return your call as soon as possible.

Telephone Calls

If you are having an emergency, please call 911. Please call the office if you have any questions regarding your medical condition, medications, and/or treatment. Most of the time a nurse will return your call and can answer most questions that you may have. Telephone calls, which are not emergencies, will be returned between 12 p.m. and 2 p.m. and after 4 p.m.

Copyright © Oncology Care Consultants.
All Rights Reserved | Privacy Policy | Sitemap | Login
Site Design by Wood Street, Inc.